Octave Ventures Llc
Venture capitalHenderson · Pre-Seed–Late Stage · 2 people tracked
Investment thesis
Octave invests in deep tech and biotech companies at various pre-IPO stages, leveraging industry experience and knowledge to support founders in advancing transformative technologies. The firm partners with entrepreneurs to facilitate growth and development of novel technical innovations.
Source: firm website, verified Jul 21, 2026.
Team · 2 people
from the firm's websiteFounder of Octave Ventures with over 30 years of experience in principal investing and investment banking. Early career as a mortgage trader with Merrill Lynch and Morgan Stanley, building relationships with major corporations and institutional investors. Sits on the board of multiple portfolio companies and co-founded Evia Life Sciences focusing on exosome diagnostics and therapeutics.
International law and global finance professional with extensive experience in fund formation, cross-border capital markets, structured finance, and private equity transactions. Formerly head of Japan for Partner Asset Facility at Credit Suisse, managing approximately US$1.9 billion in investor equity. Career primarily based in Asia across Japan, Korea, and Hong Kong.
What they invest in
from 13 of 17 portfolio companiesAI & Machine Learning ×7Biotech ×5Medical Devices ×5Defense Tech ×3Hardware ×3Deep Tech ×2Robotics ×2Enterprise Software ×1
HQs:United States×4South Korea×1
Investments · 17 tracked
founders shown can be your intro pathBeren is a public benefit corporation that develops novel medicines to treat diseases, working in partnership with patients, caregivers, clinicians, and health systems. The company focuses on advancing biology and chemistry to address disease root causes.
BiotechMedical Devices
DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations. The company aims to build a global biotech business through innovative drug development technology.
Biotech
Finch is a microbiome therapeutics company that develops innovative microbiome assets designed from human microbiota transplantation studies, targeting a range of therapeutic areas. The company holds a robust intellectual property portfolio in the microbiome field.
BiotechMedical Devices
MicroVision develops solid-state lidar sensors and perception software for autonomous vehicles, industrial automation, and defense applications. The company provides cost-effective 3D mapping and collision avoidance solutions for automotive, industrial, and security & defense markets.
AI & Machine LearningHardware
Neuraly is a clinical-stage biotechnology company developing disease-modifying treatments for neurodegenerative diseases, with a focus on inhibiting pathological glial activation to prevent neuronal cell death. The company is advancing NLY01, a candidate in Phase 2 clinical trials for Parkinson's disease.
AI & Machine LearningBiotechMedical Devices
PlenaryAI develops machine learning tools for clinical decision support, enabling physicians to analyze patient biomarkers and imaging data against large-scale analytics to improve patient outcomes. The company serves healthcare providers and clinical staff focused on precision health applications.
AI & Machine LearningHealthtechMedical DevicesBaltimore, US
Qolab applies advanced semiconductor manufacturing and integration techniques to develop superconducting quantum processors, addressing yield and component integration challenges. The company partners with semiconductor manufacturers, government agencies, and research institutions to deliver quantum hardware platforms for research and workforce development.
Deep TechQuantum ComputingSemiconductors
Red 6 builds ATARS, an AI-enabled 3D synthetic training platform for military flight training that combines human and machine learning in immersive threat environments. The system serves military warfighters and pilot training programs.
AI & Machine LearningDefense Tech
Tailos manufactures Rosie, an AI-powered commercial robot vacuum for business operations. The company designs, engineers, and supports the product from Austin, Texas, with operations spanning over 12 countries globally.
Enterprise SoftwareHardwareRoboticsAustin, US
Micah Green(Founder)
Valted Seq develops an end-to-end platform powered by robotics and AI for single-cell analysis of brain tissue, enabling biomarker and therapeutic target discovery for neurodegenerative diseases. The company operates a large single-cell genomics database supporting research into conditions like Alzheimer's and Parkinson's disease.
AI & Machine LearningBiotechMedical DevicesGaithersburg, US
Dr. Valina Dawson(Co-founder)Dr. Ted Dawson
ZeroEyes provides AI-powered visual weapon detection software that integrates with existing security cameras to identify firearms in real time. The system automatically analyzes live video feeds and routes verified detections to law enforcement and designated personnel for rapid response in schools, campuses, and other facilities.
AI & Machine LearningDefense TechSaaS
Frequently asked questions
- What stage does Octave Ventures Llc invest at?
- Octave Ventures Llc invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Octave Ventures Llc focus on?
- Octave Ventures Llc focuses on Biotech, Deep Tech.
- Where is Octave Ventures Llc located?
- Octave Ventures Llc is headquartered in Henderson, US.
Images
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Octopus Ventures is a pan-European early-stage venture capital firm that invests from pre-seed through Series A and beyond, with pre-seed investments typically at £100k and later-stage investments starting at £1 million.
F Prime Capital is an investment firm composed of scientists, engineers, physicians, operators, and investors who provide real-world expertise to help portfolio companies accelerate their path to scalable growth.
Vida Ventures is a life sciences investment firm founded by scientists, physicians, entrepreneurs and investors focused on advancing transformative biomedical innovations. The firm operates with a flexible, stage-agnostic approach across therapeutic areas.
Apple Tree Partners is a life sciences venture capital firm that creates and builds transformative biotechnology companies from early-stage science through public markets. The firm works with scientists at various stages, from pre-IP ideas to company spinouts, providing capital, strategic guidance, and operational resources.